Cns Pharmaceuticals Inc (NASDAQ:CNSP) has a beta value of 1.09 and has seen 4.02 million shares traded in the recent trading session. The CNSP stock price is -100733.33% off its 52-week high price of $121.00 and 16.67% above the 52-week low of $0.10. If we look at the company’s 10-day average daily trading volume, we find that it stood at 13.25 million shares traded. The 3-month trading volume is 14.85 million shares.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Sporting -7.56% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CNSP stock price touched $0.12 or saw a rise of 17.24%. Year-to-date, Cns Pharmaceuticals Inc shares have moved -99.82%, while the 5-day performance has seen it change -4.17%. Over the past 30 days, the shares of Cns Pharmaceuticals Inc (NASDAQ:CNSP) have changed -13.01%. Short interest in the company has seen 1.14 million shares shorted with days to cover at 0.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have a consensus price target for the stock at $0.5, which means that the shares’ value could jump 76.0% from the levels at last check today. The projected low price target is $0.5 while the price target rests at a high of $0.5. In that case, then, we find that the latest price level in today’s session is -316.67% off the targeted high while a plunge would see the stock gain -316.67% from the levels at last check today.
Cns Pharmaceuticals Inc (CNSP) estimates and forecasts
The company’s shares have lost -98.88% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 17.98% over the past 5 years.
CNSP Dividends
Cns Pharmaceuticals Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Insiders own 1.04% of the company shares, while shares held by institutions stand at 0.79% with a share float percentage of 0.80%. Investors are also buoyed by the number of investors in a company, with Cns Pharmaceuticals Inc having a total of 12.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 0.29% shares in the company for having 165.24 shares of worth $19266.0 while later fund manager owns 37.94 shares of worth $4424.0 as of Sep 30, 2024, which makes it owner of about 0.07% of company’s outstanding stock.
